Regeneron bets added cholesterol benefit will help its obesity drug stand out

Core Insights - Regeneron Pharmaceuticals' executives expressed confidence in their experimental weight-loss drug, highlighting its potential cholesterol-lowering benefits as a competitive advantage in the market [1] Company Summary - The company is focusing on the dual benefits of weight loss and cholesterol reduction, which may enhance its market position as competition in the weight-loss drug sector intensifies [1]